Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
FT US Equity Opportunities ETF
(NY:
FPX
)
127.15
+0.97 (+0.77%)
Streaming Delayed Price
Updated: 11:26 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about FT US Equity Opportunities ETF
< Previous
1
2
3
Next >
Skin-Disease Focused Biotech Castle Creek Files $100M IPO
July 19, 2021
Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS. The Company...
Via
Benzinga
Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022
July 19, 2021
Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials...
Via
Benzinga
Topics
Initial Public Offering
Exposures
COVID-19
Securities Market
Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday
July 16, 2021
Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ: GXGX), giving Celularity $138 million to push the NK cell and T cell therapies into early-...
Via
Benzinga
Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch
July 16, 2021
Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports. Alibaba Group Holding Ltd (NYSE: BABA) and Ant...
Via
Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
July 12, 2021
Tenaya Therapeutics (NASDAQ: TNYA) is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday. The biotech...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO
July 09, 2021
Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut. The IPO includes 7...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO
July 07, 2021
Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut. Nuvalent filed its S-1...
Via
Benzinga
Rare Disease Biotech Rallybio Targets $100M IPO
July 06, 2021
Rallybio Corporation (NASDAQ: RLYB) ended the first quarter with nearly $128 million in the bank, and now it has filed to raise up to $100 million in its IPO to...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
GIC-Backed WCG Clinical Plans $100M NASDAQ Debut
July 02, 2021
WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on...
Via
Benzinga
Caribou Biosciences Eyes $100M NASDAQ Debut To Propel Off-The-Shelf CAR-T Therapies In Blood Cancer
July 02, 2021
In a filing with SEC on Thursday, Caribou Biosciences (NASDAQ: CRBU) is penciling in a $100 million initial public offering. The firm expects that its new shares...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Intapp Prices IPO At $26 Per Share; Trading Begins Today
June 30, 2021
Cloud-based software solutions provider Intapp Inc (NASDAQ: INTA) priced 10.5 million shares at $26 per share in its initial public offering. The estimated gross...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
SoftBank-Backed Dingdong Downsizes U.S. IPO Target Following Missfresh Debacle: Reuters
June 29, 2021
SoftBank Group Corp (OTC: SFTBY) (OTC: SFTBF) Vision Fund II backed Chinese grocery app, Dingdong has downsized its U.S. initial public offering size to almost 25% of its...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Warehouse Robotics Company AutoStore Targets $10B IPO: Bloomberg
June 29, 2021
Norwegian warehouse robotics company, AutoStore, is exploring an initial public offering that could value it over $10 billion, Bloomberg reported. It is working with Morgan...
Via
Benzinga
Singapore's Online Marketplace Company Carousell Aims US Listing Via SPAC Merger: Bloomberg
June 28, 2021
Singapore’s online classifieds marketplace operator Carousell Pte is eyeing a U.S. listing via special purpose acquisition company (SPAC) merger at a valuation of...
Via
Benzinga
Sickle Cell Biotech, Graphite Bio Prices Upsized Initial Public Offering
June 25, 2021
Graphite Bio Inc (NASDAQ: GRPH) is set to go public on the heels of a $238 million raise less than ten months after getting started with a Series A funding of...
Via
Benzinga
Alzheimer's Biotech Acumen Pharmaceuticals Prices $125M IPO Soon After Biogen's Aduhelm Approval
June 25, 2021
Acumen Pharmaceuticals Inc has set the terms for its IPO to raise around $125 million to take ACU193, an antibody against amyloid-beta oligomers, to the end of phase 2 in...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Investors Face New Risks In Stock Market Forecast For The Next Six Months
June 24, 2021
Stocks are at a crossroads, with new risks taking shape even as the market hits new highs.
Via
Investor's Business Daily
Topics
Economy
Exposures
COVID-19
Economy
HealthCare Platform Doximity Prices Upsized IPO At $26/Share; Trading Begins Today
June 24, 2021
Doximity, Inc (NYSE: DOCS) priced 23.3 million shares at $26 per share in its initial public offering, for estimated gross proceeds are $494.3 million. The...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Hong Kong's Logistics Firm Lalamove Files Privately For $1B US IPO
June 23, 2021
Hong Kong’s on-demand logistics and delivery firm, Lalamove, or Huolala, has filed confidentially for a U.S. initial public offering (IPO) to raise a minimum of $1 billion...
Via
Benzinga
LegalZoom Aims To Raise $516M At $5B Valuation In Second US IPO Attempt: Reuters
June 21, 2021
Online legal services provider, LegalZoom, plans to sell over 19 million shares priced between $24 - $27 per share to raise $516 million at the top end of the range in its U.S....
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Software Database Firm Couchbase Files For US IPO: Reuters
June 21, 2021
Database software firm Couchbase Inc registered for a U.S. initial public offering (IPO) to tap the remote work fueled demand for data storage and processing, Reuters...
Via
Benzinga
Daniel Loeb-Backed SentinelOne Targets US IPO At Over $7B Valuation: Reuters
June 21, 2021
Billionaire investor Daniel Loeb's hedge fund, Third Point-backed cybersecurity firm SentinelOne Inc is aiming for a valuation of over $7 billion in its U.S....
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
June 11, 2021
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offer...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
China's Uber, Didi Chuxing Could Command Valuation Over $70B Based On IPO Documents: WSJ
June 11, 2021
Uber Technologies Inc’s (NYSE: UBER) Chinese counterpart, Didi Chuxing Technology Co, could fetch a valuation of over $70 billion, the Wall Street Journal...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
dLocal Prices IPO at $21 Per Share; Trading Begins Today
June 03, 2021
Technology-first payments platform, dLocal Ltd (NASDAQ: DLO), has priced 29.4 million shares, including 25 million shares from selling shareholders at $21 per share, to...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Flywire Raises $251M From IPO At $24/Share, Begins Trading Today
May 26, 2021
Payments enablement and software company Flywire Corp (NASDAQ: FLYW) priced 10.44 million shares at $24 per share to raise $250.56 million in its initial public...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Paymentus Raises $210M From IPO at $21/Share; Trading Begins Today
May 26, 2021
Cloud-based bill payment technology solutions provider, Paymentus Holdings Inc (NYSE: PAY), has priced 10 million shares at $21 per share to raise $210 million...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Biotech Firms Gyroscope Therapeutics, Talaris Therapeutics Set IPO Terms
May 03, 2021
Two prospective biotech entrants have set debut terms ahead of their launch later this week. Gyroscope Therapeutics Holdings plc is a U.K.-based Phase 2 biotech developing...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
6 ETFs That Have Fast Filled Coinbase in Their Roster
April 23, 2021
Here are six ETFs that have fast filled the cryptocurrency exchange and could be excellent choices to tap the ongoing boom.
Via
Talk Markets
Newly Launched Centessa Pharmaceuticals Plans $100M Debut On NASDAQ
April 22, 2021
Just two months after Centessa Pharmaceuticals launched after the merger of 10 private biotech companies, the company has filed a $100 million IPO for listing on NASDAQ...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.